Histone deacetylase 4 alters cartilage homeostasis in human osteoarthritis

BMC Musculoskeletal Disorders

Volumn 15, Issue 1, 2014, Pages

  Lu, Jingwei ^a   Sun, Ye ^b   Ge, Qiting ^b   Teng, Huajian ^b   Jiang, Qing ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Catabolism; Chondrocyte; HDAC4; Homeostasis; Osteoarthritis

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; COLLAGENASE 3; HISTONE DEACETYLASE 4; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; SMALL INTERFERING RNA; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; HDAC4 PROTEIN, HUMAN; HISTONE DEACETYLASE; REPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CARTILAGE; CARTILAGE CELL; CATABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEMUR CONDYLE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNEE OSTEOARTHRITIS; MALE; PATHOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TIBIA; TISSUE SECTION; TOTAL KNEE REPLACEMENT; UPREGULATION; WESTERN BLOTTING; ARTICULAR CARTILAGE; BIOSYNTHESIS; CELL CULTURE; ENZYMOLOGY; KNEE ARTHROPLASTY; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATHOLOGY; PHYSIOLOGY; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; CARTILAGE, ARTICULAR; CELLS, CULTURED; FEMALE; HISTONE DEACETYLASES; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; REPRESSOR PROTEINS;

EID: 84924245230     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-15-438     Document Type: Article

References (36)

1. Barter MJ, Bui C, Young DA: Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012, 20(5):339-349.
2. Bird A: Perceptions of epigenetics. Nature 2007, 447(7143):396-398.
3. Kouzarides T: Chromatin modifications and their function. Cell 2007, 128(4):693-705.
4. Gregoretti I, Lee Y-M, Goodson HV: Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 2004, 338(1):17-31.
5. De Ruijter A, Van Gennip A, Caron H, Kemp S, van Kuilenburg A: Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003, 370:737-749.
6. Vega RB, Matsuda K, Oh J, Barbosa AC, Yang X, Meadows E, McAnally J, Pomajzl C, Shelton JM, Richardson JA, Karsenty G, Olson EN: Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004, 119(4):555-566.
7. Young DA, Lakey RL, Pennington CJ, Jones D, Kevorkian L, Edwards DR, Cawston TE, Clark IM: Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 2005, 7(3):R503-R512.
8. Mankin HJ, Dorfman H, Lippiello L, ZARINS A: Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips II. correlation of morphology with biochemical and metabolic data. J Bone Joint Surg 1971, 53(3):523-537.
9. Saito T, Fukai A, Mabuchi A, Ikeda T, Yano F, Ohba S, Nishida N, Akune T, Yoshimura N, Nakagawa T, Nakamura K, Tokunaga K, Chung U, Kawaguchi H: Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 2010, 16(6):678-686.
10. Kawaguchi H: Regulation of osteoarthritis development by Wnt-betacatenin signaling through the endochondral ossification process. J Bone Miner Res 2009, 24(1):8-11.
11. Attur M, Patel I, Patel R, Abramson S, Amin A: Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Physicians 1997, 110(1):65-72.
12. Sahebjam S, Khokha R, Mort JS: Increased collagen and aggrecan degradation with age in the joints of Timp3-/- mice. Arthritis Rheum 2007, 56(3):905-909.
13. Blom AB, van Lent PL, Libregts S, Holthuysen AE, van der Kraan PM, van Rooijen N, van den Berg WB: Crucial role of macrophages in matrix metalloproteinase- mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 2007, 56(1):147-157.
14. Knäuper V, López-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 1996, 271(3):1544-1550.
15. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JF Jr: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Investig 1989, 84(2):678.
16. Burrage PS, Mix KS, Brinckerhoff CE: Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11(1):529-543.
17. Tortorella M, Malfait A-M, Deccico C, Arner E: The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage 2001, 9(6):539-552.
18. Quintavalla J, Kumar C, Daouti S, Slosberg E, Uziel-Fusi S: Chondrocyte cluster formation in agarose cultures as a functional assay to identify genes expressed in osteoarthritis. J Cell Physiol 2005, 204(2):560-566.
19. Bullough PG: The role of joint architecture in the etiology of arthritis. Osteoarthritis Cartilage 2004, 12:2-9.
20. Girkontaite I, Frischholz S, Lammi P, Wagner K, Swoboda B, Aigner T, von der Mark K: Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996, 15(4):231-238.
21. Walsh D, Bonnet C, Turner E, Wilson D, Situ M, McWilliams D: Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage 2007, 15(7):743-751.
22. Burrage P, Brinckerhoff C: Molecular targets in osteoarthritis: metalloproteinases and their inhibitors. Curr Drug Targets 2007, 8(2):293-303.
23. Higashiyama R, Miyaki S, Yamashita S, Yoshitaka T, Lindman G, Ito Y, Sasho T, Takahashi K, Lotz M, Asahara H: Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod Rheumatol 2010, 20(1):11-17.
24. Chang S, Young BD, Li S, Qi X, Richardson JA, Olson EN: Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10. Cell 2006, 126(2):321-334.
25. Bradley EW, Carpio LR, Westendorf JJ: Histone deacetylase 3 suppression increases PH domain and leucine-rich repeat phosphatase (Phlpp) 1 expression in chondrocytes to suppress Akt signaling and matrix secretion. J Biol Chem 2013, 288(14):9572-9582.
26. Chabane N, Zayed N, Afif H, Mfuna-Endam L, Benderdour M, Boileau C, Martel-Pelletier J, Pelletier J-P, Duval N, Fahmi H: Histone deacetylase inhibitors suppress interleukin-1β-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage 2008, 16(10):1267-1274.
27. Wang X, Song Y, Jacobi JL, Tuan RS: Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. Growth Factors 2009, 27(1):40-49.
28. Chen W-P, Bao J-P, Hu P-F, Feng J, Wu L-D: Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol Biol Rep 2010, 37(8):3967-3972.
29. Nasu Y, Nishida K, Miyazawa S, Komiyama T, Kadota Y, Abe N, Yoshida A, Hirohata S, Ohtsuka A, Ozaki T: Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis Cartilage 2008, 16(6):723-732.
30. Hong S, Derfoul A, Pereira-Mouries L, Hall DJ: A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J 2009, 23(10):3539-3552.
31. Culley KL, Hui W, Barter MJ, Davidson RK, Swingler TE, Destrument AP, Scott JL, Donell ST, Fenwick S, Rowan AD, Young DA, Clark IM: Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. Arthritis Rheum 2013, 65(7):1822-1830.
32. Bottomley MJ, Surdo PL, Di Giovine P, Cirillo A, Scarpelli R, Ferrigno F, Jones P, Neddermann P, De Francesco R, Steinkühler C: Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem 2008, 283(39):26694-26704.
33. Schuetz A, Min J, Allali-Hassani A, Schapira M, Shuen M, Loppnau P, Mazitschek R, Kwiatkowski NP, Lewis TA, Maglathin RL: Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. J Biol Chem 2008, 283(17):11355-11363.
34. Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M, Ito T, Asahara H: Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 2005, 280(42):35203-35208.
35. Huh YH, Ryu JH, Chun JS: Regulation of type II collagen expression by histone deacetylase in articular chondrocytes. J Biol Chem 2007, 282(23):17123-17131.
36. Zayed N, El Mansouri FE, Chabane N, Kapoor M, Martel-Pelletier J, Benderdour M, Pelletier J-P, Duval N, Fahmi H: Valproic acid suppresses interleukin-1ssinduced microsomal prostaglandin E2 synthase-1 expression in chondrocytes through upregulation of NAB1. J Rheumatol 2011, 38(3):492-502.